Menopause and vascular endothelial health: Is it all about the oestrogen?
Abstract Cardiovascular disease (CVD) is a leading cause of mortality in women, and CVD risk is accelerated during the menopause transition. This acceleration has traditionally been attributed to the hallmark decline in oestradiol with menopause. However, the menopause transition is also characterized by changes in other sex hormones that exert effects
Virginia R. Nuckols +4 more
wiley +1 more source
Miscarriage history is not associated with embryonic aneuploidy in women under 38 years of age with recurrent pregnancy loss. [PDF]
Miao SB +5 more
europepmc +1 more source
Variability of endocrine findings with age and clinical severity in the long-term follow-up of pseudohypoparathyroidism: evidence of TRH resistance with central hypothyroidism. [PDF]
Senkalfa B +6 more
europepmc +1 more source
Evaluating progestin-primed and GnRH antagonist ovarian stimulation protocols in PGT-A cycles: implications for clinical practice. [PDF]
Elmas B +8 more
europepmc +1 more source
Luteinizing hormone-releasing hormone in prostate cancer treatment: from hypothalamic discovery to clinical translation. [PDF]
Benisti S, Saad F, Delouya G, Taussky D.
europepmc +1 more source
Post-cycle therapy after androgen abuse: a narrative review of mechanisms, evidence, and clinical perspectives. [PDF]
Smit DL +3 more
europepmc +1 more source
Gonadotropin-releasing hormone agonists during cyclophosphamide for ovarian protection in systemic lupus erythematosus. [PDF]
Maiorano MFP +5 more
europepmc +1 more source
Stress-associated testosterone suppression: central adaptation or hypogonadism?
Friedl KE, Nindl BC, Potter AW.
europepmc +1 more source
Related searches:
Samuel Aparicio +2 more
exaly

